Satellite operator AST soared over 45% and cooperated with AT&T to provide satellite communication services

Gelonghui, May 16 | Satellite operator AST SpaceMobile (ASTS.US) soared over 45% to US$3.47

Gelonghui, May 16 | Satellite operator AST SpaceMobile (ASTS.US) surged over 45% to US$3.47.
According to the news, AT&T has cooperated with AST SpaceMobile to provide satellite communication services to its mobile phone users. It will compete with SpaceX and T-Mobile US.
The cooperation arrangement is expected to start within three months and last until 2030. For the time being, it only covers the United States and Japan.

Like (0)
Previous May 16, 2024 11:25 pm
Next May 16, 2024 11:25 pm

Related posts

  • Stocks research firm MarketsMojo plans to raise $20-50 mn

    MarketsMojo, a stocks research and analysis firm, is planning to raise $20-50 million in Series A funding, with 10-15 per cent equity dilution as it ramps up its business, in the 21 countries where it provides its services, in the next 1-2 years.

    US stock market April 29, 2024
  • Blackstone-backed Aadhar Housing Finance issue opens today at ₹300-315

    The initial public offering of Aadhar Housing Finance opens for the public today. The IPO comes at a price band of ₹300-315. It IPO closes on May 10 and the market lot is .47 shares

    US stock market May 8, 2024
  • Client Associates achieves first close of maiden Cat-II Alternate Fund at ₹ 300 crore

    Client Associates, a wealth management firm and the country’s largest multi-office service provider, has forayed into asset management with the first close of its maiden fund —Client Associates Alternate Fund (CAAF), mopping up as much as ₹300 crore.

    US stock market May 8, 2024
  • Nordisk fell 1.1% in premarket as the U.S. Senate launches investigation into Novo Nordisk\’s GLP-1 drug pricing

    Gelonghui, April 25 | Nord Nordisk (NVO.US) U.S. stocks fell 1.1% before the market opened, to US$124.74. On the news, U.S. Senate Health, Education, Labor and Pensions Committee Chairman Bernie Sanders said on Wednesday that the committee is launching an investigation into Novo Nordisk\’s pricing. In a letter sent to Novo Nordisk\’s CEO on Wednesday, Sanders asked Novo Nordisk to provide \”internal communications about the U.S. pricing of the drug\” and explain why Ozempic and Wegovy have the same ingredient (semaglutide). ), Wegovy’s pricing is obviously more expensive. Sanders stressed that the price of GLP-1 drugs \”must come down\” so that consumers can afford them and the government doesn\’t go bankrupt by reimbursing them.

    US stock market April 25, 2024
  • Kirloskar Pneumatic Company’s shares surge 12.10% on stronger revenue, profit in FY24

    Kirloskar Pneumatic Company Ltd’s shares surged 12.10 per cent after the company announced its financial results for FY24, reporting a 7 per cent growth in revenue and a 25 per cent growth in profit before tax as compared with the earnings in FY23. The company’s net profit after tax has increased by over 23 per cent. KPCL declared a final dividend of 200 per cent at ₹4 per share, in addition to the interim dividend of 125 per cent, bringing the total dividend to ₹6.50 per share (325 per cent).

    US stock market April 26, 2024
  • Biocon Biologics gains FDA approval for Yesafili, shares up

    Biocon Biologics Ltd, a subsidiary of Biocon Ltd, secured U.S. FDA approval for Yesafili, an interchangeable biosimilar to Eylea (aflibercept). Yesafili is designed to treat ophthalmological conditions, including neovascular age-related macular degeneration, visual impairment due to macular edema secondary to retinal vein occlusion, diabetic macular edema, and myopic choroidal neovascularization.

    US stock market May 21, 2024